Cancers, Vol. 16, Pages 1630: Patient-Reported Outcomes after Laser Ablation for Bladder Tumours Compared to Transurethral Resection & mdash;A Prospective Study

Cancers, Vol. 16, Pages 1630: Patient-Reported Outcomes after Laser Ablation for Bladder Tumours Compared to Transurethral Resection—A Prospective Study Cancers doi: 10.3390/cancers16091630 Authors: Nina Nordtorp Deacon Ninna Kjær Nielsen Jørgen Bjerggaard Jensen The standard procedure for diagnosis and treatment of bladder tumours, transurethral resection of bladder tumour (TURBT), is associated with a complication rate of up to 26% and potentially has severe influence on patient-reported outcomes (PRO). Outpatient transurethral laser ablation (TULA) is an emerging new modality that is less invasive with a lower risk of complications and, thereby, possibly enhanced PRO. We collected PRO following transurethral procedures in treatment of bladder tumours to evaluate any clinically relevant differences in symptoms and side effects. This prospective observational study recruited consecutive patients undergoing different bladder tumour-related transurethral procedures. Patients filled out questionnaires regarding urinary symptoms (ICIQ-LUTS), postoperative side effects, and quality of life (EQ-5D-3L) at days 1 and 14 postoperatively. In total, 108 patients participated. The most frequently reported outcomes were postoperative haematuria and pain. Patients undergoing TURBT reported longer lasting haematuria, a higher perception of pain, and a more negative impact on quality of life compared to patients undergoing TULA. TURBT-treated patients had more cases ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research